Diabetes and non-diabetic patients with coronary heart disease diffuse long coronary lesions after sirolimus—eluting stents can significantly improve the prognosis of one year.
糖尿病与非糖尿病冠心病患者冠脉弥漫长病变经雷帕霉素药物涂层支架治疗可以明显改善预后。
参考来源 - 糖尿病与非糖尿病冠心病患者冠脉弥漫长病变经介入治疗的预后观察Sirolimus belongs to macrocyclic lactone produced by Streptomyces hygroscopicu. Now Sirolimus oral solution ,which containing 50mg Sirolimus per 50 ml, has already been used in clinic.
西罗莫司是由链球菌(Streptomyces hygroscopicu)产生的一种大环内酯类抗免疫抗生素,目前国内有西罗莫司口服液用于临床,规格为50mg/50ml,口服溶液要求避光保存于2-8℃(36-46℉)的冰箱内。
参考来源 - 固体分散技术在西罗莫司胶囊中的应用·2,447,543篇论文数据,部分数据来源于NoteExpress
The FDA is determining whether a labeling change for sirolimus is needed.
FDA正在酝酿是否需要修改西罗莫司的标签信息。
Proteinuria was associated with the presence of graft glomerular pathology and the use of sirolimus.
蛋白尿症与肾小球的病变以及西罗莫司(免疫抑制剂)的使用相关。
Sirolimus is indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiving kidney transplants.
西罗莫司用于在13岁及以上接受肾移植患者中预防器官排斥反应。
应用推荐